Nerve block offers hope for migraine sufferers Who've tried everything
NCT ID NCT06891118
First seen Mar 03, 2026 · Last updated Jun 22, 2026 · Updated 21 times
Summary
This study tested a nerve block called a stellate ganglion block for people with chronic migraine that didn't get better with other treatments. 42 patients received the injection under ultrasound guidance. Researchers tracked changes in monthly headache days and pain scores over 6 months to see if the procedure helped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE HEADACHE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya, 06800, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stellate ganglion block (nerve block injection)
What this could lead to
If effective, this nerve block could offer a new option for people with chronic migraine who haven't found relief from standard treatments.
What could go wrong
This is a small, single-center study with no control group, so results may not apply widely. The procedure carries risks like bleeding, infection, or nerve damage.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.